Merit Medical terminates Justin Lampropoulos as President, EMEA, effective Oct 19

MERIT MEDICAL SYSTEMS INC

Justin Lampropoulos terminated as President, Europe, Middle East and Africa effective October 19, 2021.
No successor or interim replacement announced for the regional president role.
Termination executed through a wholly-owned subsidiary; no reason disclosed.
Company's day-to-day operations continue under existing management structure.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Justin Lampropoulos

President, Europe, Middle East and Africa

MMSI · MERIT MEDICAL SYSTEMS INC

Effective: 2021-10-19
Filed: October 22, 2021, 7:59 PM ET

Effective as of October 19, 2021, Merit Medical Systems, Inc., through a wholly-owned subsidiary, terminated the employment of Justin Lampropoulos, President, Europe, Middle East and Africa.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Justin Lampropoulos was terminated as President, Europe, Middle East and Africa at MERIT MEDICAL SYSTEMS INC.

Action: terminated
Role: President, Europe, Middle East and Africa

Exact text from the filing

Effective as of October 19, 2021, Merit Medical Systems, Inc., through a wholly-owned subsidiary, terminated the employment of Justin Lampropoulos, President, Europe, Middle East and Africa.

View on SEC.gov

MERIT MEDICAL SYSTEMS INC filing history →

Source: SEC EDGAR

accession 0000856982-21-000025

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.